ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0371

Arterial Lesions in Primary Podocytopathies in Young Adults Are Associated with Glomerular Vascular Endothelial Growth Factor Expression and Poorer Kidney Outcomes

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Braga Barbosa, Gessica Sabrine, Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Ledesma, Felipe Lourenco, Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Camara, Niels Olsen Saraiva, Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Oliveira, Ivone Braga de, Universidade de Sao Paulo, São Paulo, SP, Brazil
  • Dias, Cristiane B., Universidade de Sao Paulo, São Paulo, SP, Brazil
Background

Vascular endothelial growth factor (VEGF) is the major mediator of abnormal angiogenesis in diabetic glomeruli. The role of arterial lesions (AL) and VEGF expression in non-diabetic and young individuals with primary podocytopathies has received little attention.

Methods

We analyzed primary FSGS and MCD in young adults, dividing them into 2 groups according to presence or absence of histological AL (arteriosclerosis, AS; arteriolar hyalinosis, AH). VEGF-A expression was evaluated by immunohistochemistry (IHC).

Results

Based on 40 cases of podocytopathy with available tissue to perform IHC, 22 had AL (AS in 40%, AH in 32%, and AS + AH in 27%). The AL group presented with higher mean age (33 ±8 vs 26 ±10, p 0.02), with no difference in proportion of hypertension (36% vs 31%). The AL group presented with lower kidney function at the diagnosis (102 vs 127.5 ml/min/1.73m2, p 0.008), most notably when AS + AH were presented (69.5 vs 127.5, p 0.01). After 4 years, the AL group also had the lowest eGFR (91.5 vs 117.5, p 0.005), especially when AS + AH were identified (57 vs 117.5, p 0.003). No difference in global sclerosis and IFTA was found. The performed IHC revealed higher glomerular VEGF expression in AL group (10.9 vs 3.9, p 0.017, Figure 1), most notably when AS + AH were found (Table 1).

Conclusion

Young adults with primary podocytopathy-associated arterial lesions (arteriosclerosis / arteriolar hyalinosis) have a poorer renal prognosis. Higher glomerular VEGF expression in podocytopathies with arterial lesions suggests an imbalance between dysregulated podocytes and vascular endothelial homeostasis.